Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and in Escherichia coli Containing a Cloned H. pylori rdxA + (Nitroreductase) Gene
- 15 September 2000
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 182 (18) , 5091-5096
- https://doi.org/10.1128/jb.182.18.5091-5096.2000
Abstract
Much of the normal high sensitivity of wild-type Helicobacter pylori to metronidazole (Mtz) depends on rdxA(HP0954), a gene encoding a novel nitroreductase that catalyzes the conversion of Mtz from a harmless prodrug to a bactericidal agent. Here we report that levels of Mtz that partially inhibit growth stimulate forward mutation to rifampin resistance inrdxA+ (Mtzs) and also inrdxA (Mtzr) H. pylori strains, and that expression of rdxA in Escherichia coliresults in equivalent Mtz-induced mutation. A reversion test using defined lac tester strains of E. coli carryingrdxA+ indicated that CG-to-GC transversions and AT-to-GC transitions are induced more frequently than other base substitutions. Alkaline gel electrophoretic tests showed that Mtz concentrations near or higher than the MIC for growth also caused DNA breakage in H. pylori and in E. coli carryingrdxA+, suggesting that this damage may account for most of the bactericidal action of Mtz. Coculture of MtzsH. pylori with E. coli (highly resistant to Mtz) in the presence of Mtz did not stimulate forward mutation in E. coli, indicating that the mutagenic and bactericidal products of Mtz metabolism do not diffuse significantly to neighboring (bystander) cells. Our results suggest that the widespread use of Mtz against other pathogens in people chronically infected withH. pylori may stimulate mutation and recombination inH. pylori, thereby speeding host-specific adaptation, the evolution of virulence, and the emergence of resistance against Mtz and other clinically useful antimicrobials.Keywords
This publication has 34 references indexed in Scilit:
- Resistance to the nitroheterocyclic drugsPublished by Elsevier ,2002
- Analysis of p53 Gene Mutations in Helicobacter pylori-Associated Gastritis Mucosa in Endoscopic Biopsy SpecimensScandinavian Journal of Gastroenterology, 1999
- Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen‐insensitive NADPH nitroreductaseMolecular Microbiology, 1998
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Antimicrobial Resistance in AnaerobesClinical Infectious Diseases, 1997
- Development of a method based on alkaline gel electrophoresis for estimation of oxidative damage to DNA in Escherichia coliJournal of Applied Bacteriology, 1996
- Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of actionJournal of Antimicrobial Chemotherapy, 1993
- A set of lacZ mutations in Escherichia coli that allow rapid detection of each of the six base substitutions.Proceedings of the National Academy of Sciences, 1989
- Role of the phosphoroclastic reaction of Clostridium pasteurianum in the reduction of metronidazoleAntimicrobial Agents and Chemotherapy, 1985
- Antitrichomonad Action, Mutagenicity, and Reduction of Metronidazole and Other NitroimidazolesAntimicrobial Agents and Chemotherapy, 1976